Karyopharm Therapeutics Inc (KPTI) — Defensive Interval Ratio
Karyopharm Therapeutics Inc (KPTI) has a Defensive Interval Ratio of 109 days as of June 2026. Defensive assets of $40.00 Million (cash $-, short-term investments $10.12 Million, receivables $29.87 Million) cover 109 days of daily cash needs of $367.76K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Karyopharm Therapeutics Inc Defensive Interval Ratio (2013–2025)
This chart shows how Karyopharm Therapeutics Inc's Defensive Interval Ratio has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 109 days, meaning defensive assets of $40.00 Million can fund 109 days of operations without new revenue. For the complete balance sheet picture, see how large is Karyopharm Therapeutics Inc's balance sheet.
Annual Defensive Interval Ratio for Karyopharm Therapeutics Inc (2013–2025)
The table below presents the year-by-year Defensive Interval Ratio for Karyopharm Therapeutics Inc from 2013 to 2025, covering 13 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Karyopharm Therapeutics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 116 days | $29.38 Million | $252.22K/day | $- | $3.20 Million | ▼ -188 days |
| 2024 | 305 days | $77.00 Million | $252.78K/day | $- | $46.24 Million | ▼ -568 days |
| 2023 | 873 days | $166.17 Million | $190.35K/day | $- | $139.21 Million | ▼ -179 days |
| 2022 | 1051 days | $189.87 Million | $180.57K/day | $- | $142.78 Million | ▲ +751 days |
| 2021 | 300 days | $60.65 Million | $201.97K/day | $- | $38.16 Million | ▼ -216245 days |
| 2020 | 216546 days | $176.20 Million | $813.70/day | $- | $163.32 Million | ▲ +215436 days |
| 2019 | 1110 days | $140.96 Million | $126.99K/day | $- | $133.10 Million | ▼ -526 days |
| 2018 | 1636 days | $210.18 Million | $128.50K/day | $- | $210.18 Million | ▲ +1064 days |
| 2017 | 572 days | $77.47 Million | $135.53K/day | $- | $77.47 Million | ▼ -1198 days |
| 2016 | 1770 days | $79.89 Million | $45.14K/day | $- | $79.89 Million | ▼ -1059 days |
| 2015 | 2829 days | $117.28 Million | $41.46K/day | $- | $117.28 Million | ▲ +1193 days |
| 2014 | 1635 days | $55.12 Million | $33.70K/day | $- | $55.12 Million | ▲ +1635 days |
| 2013 | 0 days | $0.00 | $9.02K/day | $- | $0.00 | — |